Fanger MW - Search Results

1

Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.

Murad JM, Baumeister SH, Werner L, Daley H, Trébéden-Negre H, Reder J, Sentman CL, Gilham D, Lehmann F, Snykers S, Sentman ML, Wade T, Schmucker A, Fanger MW, Dranoff G, Ritz J, Nikiforow S. Murad JM, et al. Among authors: fanger mw. Cytotherapy. 2018 Jul;20(7):952-963. doi: 10.1016/j.jcyt.2018.05.001. Epub 2018 Jun 29. Cytotherapy. 2018. PMID: 30180944 Free PMC article.

2

Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated Mice.

Sentman ML, Murad JM, Cook WJ, Wu MR, Reder J, Baumeister SH, Dranoff G, Fanger MW, Sentman CL. Sentman ML, et al. Among authors: fanger mw. J Immunol. 2016 Dec 15;197(12):4674-4685. doi: 10.4049/jimmunol.1600769. Epub 2016 Nov 14. J Immunol. 2016. PMID: 27849169 Free PMC article.

3

Targeting of intragraft reactive oxygen species by APP-103, a novel polymer product, mitigates ischemia/reperfusion injury and promotes the survival of renal transplants.

Minami K, Bae S, Uehara H, Zhao C, Lee D, Iske J, Fanger MW, Reder J, Morrison I, Azuma H, Wiens A, Van Keuren E, Houser B, ElKhal A, Kang PM, Tullius SG. Minami K, et al. Among authors: fanger mw. Am J Transplant. 2020 Jun;20(6):1527-1537. doi: 10.1111/ajt.15794. Epub 2020 Feb 22. Am J Transplant. 2020. PMID: 31991042 Free PMC article.

4

Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcgammaRI and the epidermal growth factor receptor.

Wallace PK, Romet-Lemonne JL, Chokri M, Kasper LH, Fanger MW, Fadul CE. Wallace PK, et al. Among authors: fanger mw. Cancer Immunol Immunother. 2000 Nov;49(9):493-503. doi: 10.1007/s002620000142. Cancer Immunol Immunother. 2000. PMID: 11092616

5

Anti-body-dependent cellular cytotoxicity (ADCC) function of peripheral blood polymorphonuclear neutrophils (PMN) after autologous bone marrow transplantation (ABMT).

Ericson SG, Guyre CA, Benoit NE, Meehan KR, Mills LE, Fanger MW. Ericson SG, et al. Among authors: fanger mw. Bone Marrow Transplant. 1995 Dec;16(6):787-91. Bone Marrow Transplant. 1995. PMID: 8750271

6

Production and use of anti-FcR bispecific antibodies.

Fanger MW, Graziano RF, Guyre PM. Fanger MW, et al. Immunomethods. 1994 Feb;4(1):72-81. doi: 10.1006/immu.1994.1009. Immunomethods. 1994. PMID: 8069530 Review.

7

Bispecific-armed, interferon gamma-primed macrophage-mediated phagocytosis of malignant non-Hodgkin's lymphoma.

Ely P, Wallace PK, Givan AL, Graziano RF, Guyre PM, Fanger MW. Ely P, et al. Among authors: fanger mw. Blood. 1996 May 1;87(9):3813-21. Blood. 1996. PMID: 8611707 Free article.

8

The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation.

Ericson SG, Benoit NE, Mills LE, Fanger MW. Ericson SG, et al. Among authors: fanger mw. Exp Hematol. 1994 Mar;22(3):283-9. Exp Hematol. 1994. PMID: 7509291

9

Fc gamma R-mediated killing by eosinophils.

Graziano RF, Looney RJ, Shen L, Fanger MW. Graziano RF, et al. Among authors: fanger mw. J Immunol. 1989 Jan 1;142(1):230-5. J Immunol. 1989. PMID: 2521234

10

Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.

Connor RI, Shen L, Fanger MW. Connor RI, et al. Among authors: fanger mw. J Immunol. 1990 Sep 1;145(5):1483-9. J Immunol. 1990. PMID: 1696598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page